RIAZZINO, Switzerland, March 03, 2026--(BUSINESS WIRE)--Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP) ...
The EDQM grants Gnosis a CEP for teicoplanin, a true fermentation glycopeptide antibiotic produced by actinoplanes teichomyceticus strains. The European Directorate for the Quality of Medicines (EDQM) ...
Brains Bioceutical Corps. wholly-owned subsidiary BSPG Laboratories in Sandwich Kent · GlobeNewswire Inc. SANDWICH, United Kingdom, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp. (BBC) has ...
Linnea is proud to announce that its Cannabidiol (CBD) Isolate has been granted a Certificate of Suitability to the European Pharmacopoeia (CEP). The CEP serves to attest that the quality of an active ...
Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare Advancing Pharmaceutical Innovation ...
The MarketWatch News Department was not involved in the creation of this content. Brains Bioceutical Set to Achieve One of the World's First CEP for Cannabidiol Certification with the European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results